Monthly Prescribing Reference

Dissolution Test Failure Prompts Recall of Anagrelide Capsules

Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...
Nasdaq

Neurocrine Biosciences Presents Data on In Vitro Dissolution Performance of INGREZZA® (valbenazine) Capsule Contents via Soft Foods or Feeding Tube at AMDA - PALTC 2023 Annual ...

SAN DIEGO, March 9, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced it will present data from three in vitro dissolution studies exploring the dissolution performance ...
techtimes

FDA Announces Recall of Blood Pressure Capsules Over Heart Attack Risk

More than 130 batches of potassium chloride capsules, prescribed to those with hypokalaemia, have been recalled for a dissolution issue that could elevate potassium to life-threatening levels, ...
Nasdaq

Glenmark Recalls Potassium Chloride Extended-Release Capsules

(RTTNews) - Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc., USA is recalling 114 batches of Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K citing failed dissolution, ...
USA Today

Glenmark Pharmaceuticals Inc., USA Issues Voluntary Nationwide Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due to Failed Dissolution

Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The product is being ...
Monthly Prescribing Reference

Hyperkalemia Risk Possible With Recalled Potassium Chloride ER Capsules

At this time, there have been no reports of injury related to this recall. Glenmark Pharmaceuticals is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750mg) 10 mEq K due ...